We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMCC
1026
DELISTED
Old Market Capital Corp
OMCC
$136K ﹤0.01%
24,894
-331
-1% -$1.86K
LCTX icon
1027
Lineage Cell Therapeutics
LCTX
$284M
$136K ﹤0.01%
150,000
-17,900
-11% -$10.6K
PETS icon
1028
PetMed Express
PETS
$42.1M
$135K ﹤0.01%
40,800
+20,000
+96% +$71.2K
SOND
1029
DELISTED
Sonder
SOND
$135K ﹤0.01%
50,000
– –
ABOS icon
1030
Acumen Pharmaceuticals
ABOS
$162M
$134K ﹤0.01%
115,171
– –
INTT icon
1031
inTEST
INTT
$179M
$132K ﹤0.01%
18,200
– –
AIP icon
1032
Arteris
AIP
$1.43B
$130K ﹤0.01%
13,600
– –
VATE icon
1033
INNOVATE Corp
VATE
$103M
$129K ﹤0.01%
25,000
– –
AMTX icon
1034
Aemetis
AMTX
$109M
$129K ﹤0.01%
51,900
– –
YARW
1035
Yarrow Bioscience, Inc. Common Stock
YARW
$25.2M
$127K ﹤0.01%
1,539
+500
+48% +$32.5K
SERA icon
1036
Sera Prognostics
SERA
$78.3M
$127K ﹤0.01%
45,705
-45,000
-50% -$111K
BMEA icon
1037
Biomea Fusion
BMEA
$91.1M
$127K ﹤0.01%
70,300
+35,000
+99% +$67.4K
BFLY icon
1038
Butterfly Network
BFLY
$2.24B
$126K ﹤0.01%
63,000
-35,000
-36% -$80.4K
TACT icon
1039
Transact Technologies
TACT
$58M
$126K ﹤0.01%
34,845
– –
RAPT
1040
DELISTED
RAPT Therapeutics
RAPT
$125K ﹤0.01%
15,625
+3,125
+25% +$23.8K
MCHX icon
1041
Marchex
MCHX
$80.6M
$123K ﹤0.01%
56,828
– –
UHG
1042
DELISTED
United Homes Group
UHG
$122K ﹤0.01%
42,000
+27,000
+180% +$70.2K
XTNT icon
1043
Xtant Medical Holdings
XTNT
$61.7M
$121K ﹤0.01%
164,100
-25,000
-13% -$14.2K
GEG icon
1044
Great Elm Group
GEG
$67.7M
$119K ﹤0.01%
56,545
– –
ANRO icon
1045
Alto Neuroscience
ANRO
$1.09B
$119K ﹤0.01%
54,100
+25,000
+86% +$59.5K
AKA icon
1046
a.k.a. Brands
AKA
$122M
$118K ﹤0.01%
+11,475
New +$127K
SVCO
1047
Silvaco Group
SVCO
$278M
$118K ﹤0.01%
+25,000
New +$118K
NTIC icon
1048
Northern Technologies International Corp
NTIC
$80.5M
$116K ﹤0.01%
15,661
– –
JVA icon
1049
Coffee Holding Co
JVA
$19.9M
$116K ﹤0.01%
26,758
+3,389
+15% +$12.5K
VTYX
1050
DELISTED
Ventyx Biosciences
VTYX
$115K ﹤0.01%
53,600
-45,000
-46% -$72.7K
40 41
42
43 44

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.